Patents by Inventor Jessica L. Foley

Jessica L. Foley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8926635
    Abstract: A novel occluder application and clip device for treatment of embolic stroke caused by atrial fibrillation uses multiple sutures in a non directional handle to affix the occlusion device to the applicator and manipulate the occluder from an open and receiving position to a closed and occluding position. The occluder is retained in place by a clamping means related to locks retainers, resilient material or otherwise. An actuator mechanism is used to manipulate the occluder to a locked or occluding position. The applicator with the occluder attached has a low profile and remote manipulations to allow the occluder to be delivered to the clamping location within a patient through a small incision or delivery port such as a trocar cannula or the like.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: January 6, 2015
    Assignee: Medtronic, Inc.
    Inventors: David E. Francischelli, Roderick E. Briscoe, Leonard H. Leuer, Daniel C. Haeg, Tom P. Daigle, David Kim, Mark T. Stewart, Andrew L. Olson, Patrick J. Cloutier, Christopher W. Smith, Michael J. Hobday, Tessy Kanayinkal, Douglas H. Gubbin, Paul T. Rothstein, Joseph E. Cardinal, Jessica L. Foley, Christopher J. Plott
  • Patent number: 8663245
    Abstract: The invention provides a system for occluding a left atrial appendage of a patient. The system can include a ring occluder that can be positioned around the left atrial appendage and a ring applicator to position the ring occluder with respect to the left atrial appendage. The system can also provide a tissue-grasping tool that is separable from the ring applicator tool.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: March 4, 2014
    Assignee: Medtronic, Inc.
    Inventors: David E. Francischelli, Roderick E. Briscoe, Leonard H. Leuer, Daniel C. Haeg, Tom P. Daigle, David Kim, Mark T. Stewart, Andrew L. Olson, Patrick J. Cloutier, Christopher W. Smith, Michael J. Hobday, Tessy Kanayinkal, Douglas H. Gubbin, Paul T. Rothstein, Joseph E. Cardinal, Jessica L. Foley, Christopher J. Plott
  • Publication number: 20120316426
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic effect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Application
    Filed: August 20, 2012
    Publication date: December 13, 2012
    Applicant: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little
  • Patent number: 8211017
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic effect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: July 3, 2012
    Assignee: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little
  • Patent number: 8206299
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic effect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: June 26, 2012
    Assignee: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little
  • Patent number: 8197409
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic effect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: June 12, 2012
    Assignee: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little
  • Publication number: 20110040171
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic effect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Application
    Filed: September 21, 2010
    Publication date: February 17, 2011
    Applicant: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little
  • Publication number: 20110040214
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic effect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Application
    Filed: September 21, 2010
    Publication date: February 17, 2011
    Applicant: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little
  • Publication number: 20110009734
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic effect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Application
    Filed: September 21, 2010
    Publication date: January 13, 2011
    Applicant: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little
  • Publication number: 20100234728
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic affect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversibly block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Application
    Filed: February 23, 2009
    Publication date: September 16, 2010
    Applicant: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little
  • Publication number: 20100145361
    Abstract: A novel occluder application and clip device for treatment of embolic stroke caused by atrial fibrillation uses multiple sutures in a non directional handle to affix the occlusion device to the applicator and manipulate the occluder from an open and receiving position to a closed and occluding position. The occluder is retained in place by a clamping means related to locks retainers, resilient material or otherwise. An actuator mechanism is used to manipulate the occluder to a locked or occluding position. The applicator with the occluder attached has a low profile and remote manipulations to allow the occluder to be delivered to the clamping location within a patient through a small incision or delivery port such as a trocar cannula or the like.
    Type: Application
    Filed: October 2, 2009
    Publication date: June 10, 2010
    Inventors: David E. Francischelli, Roderick E. Briscoe, Leonard H. Leuer, Daniel C. Haeg, Tom P. Daigle, David Kim, Mark T. Stewart, Andrew L. Olson, Patrick J. Cloutier, Christopher W. Smith, Michael J. Hobday, Tessy Kanayinkal, Douglas H. Gubbin, Paul T. Rothstein, Joseph E. Cardinal, Jessica L. Foley, Christopher J. Plott
  • Patent number: 7510536
    Abstract: A method for using high intensity focused ultrasound (HIFU) to treat neurological structures to achieve a desired therapeutic affect. Depending on the dosage of HIFU applied, it can have a reversible or irreversible effect on neural structures. For example, a relatively high dose of HIFU can be used to permanently block nerve function, to provide a non-invasive alternative to severing a nerve to treat severe spasticity. Relatively lower doses of HIFU can be used to reversible a block nerve function, to alleviate pain, to achieve an anesthetic effect, or to achieve a cosmetic effect. Where sensory nerves are not necessary for voluntary function, but are involved in pain associated with tumors or bone cancer, HIFU can be used to non-invasively destroy such sensory nerves to alleviate pain without drugs. Preferably, ultrasound imaging synchronized to the HIFU therapy is used to provide real-time ultrasound image guided HIFU therapy of neural structures.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: March 31, 2009
    Assignee: University of Washington
    Inventors: Jessica L. Foley, Shahram Vaezy, James W. Little